MDUFMA II under scrutiny, post-market fees considered

05/24/2007 | Medical Devices Today

This analysis of the proposed Medical Device User Fee & Modernization Act looks at areas in the bill that deal with speeding up the premarket review process, funding, third-party issues and patient safety. One member of the House subcommittee charged with overseeing reauthorization of the user fee has suggested that some of the money be allotted for post-market surveillance to enhance safety.

View Full Article in:

Medical Devices Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD